Updated: Jun 23, 2026

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
Weitong Gao1, Ruqiong Wang1, Bo An1
1Department of Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
RNA-binding motif 10 (RBM10) deficiency in lung adenocarcinoma (LUAD) creates an immunosuppressive tumor microenvironment. Targeting the CCL7-CCR2 pathway can restore anti-PD-1 therapy efficacy in RBM10-deficient LUAD.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: